Correlation Between Third Harmonic and Eliem Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Third Harmonic and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Third Harmonic and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Third Harmonic Bio and Eliem Therapeutics, you can compare the effects of market volatilities on Third Harmonic and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Third Harmonic with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Third Harmonic and Eliem Therapeutics.

Diversification Opportunities for Third Harmonic and Eliem Therapeutics

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between Third and Eliem is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Third Harmonic Bio and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Third Harmonic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Third Harmonic Bio are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Third Harmonic i.e., Third Harmonic and Eliem Therapeutics go up and down completely randomly.

Pair Corralation between Third Harmonic and Eliem Therapeutics

Given the investment horizon of 90 days Third Harmonic Bio is expected to generate 0.66 times more return on investment than Eliem Therapeutics. However, Third Harmonic Bio is 1.52 times less risky than Eliem Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.15 per unit of risk. If you would invest  1,246  in Third Harmonic Bio on June 30, 2024 and sell it today you would earn a total of  104.00  from holding Third Harmonic Bio or generate 8.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy97.73%
ValuesDaily Returns

Third Harmonic Bio  vs.  Eliem Therapeutics

 Performance 
       Timeline  
Third Harmonic Bio 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Third Harmonic Bio are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Third Harmonic may actually be approaching a critical reversion point that can send shares even higher in October 2024.
Eliem Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in October 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Third Harmonic and Eliem Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Third Harmonic and Eliem Therapeutics

The main advantage of trading using opposite Third Harmonic and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Third Harmonic position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.
The idea behind Third Harmonic Bio and Eliem Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Stocks Directory
Find actively traded stocks across global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges